Search ↗

Clinics

Hair loss telehealth

Who prescribes hair-loss treatment online, and what the subscriptions include.

4 providers offer this. 1 include labs in the price. 1 accept insurance. Figures reflect what each provider publishes. * = provisional score.

Highest-scored providers

#1 Ro logo Ro 9.0

Adults who want brand-name, FDA-approved GLP-1s with transparent cash pricing or help using commercial insurance, and who are comfortable with an online, message-based model.

Read the review → #2 Keeps 8.3*

Men seeking online finasteride/minoxidil-based hair-loss treatment on a multi-month shipping plan who are comfortable with all-sales-final terms.

Read the review → #3 Maximus logo Maximus 6.8*

Men who want fertility-sparing testosterone options such as enclomiphene or oral T with published prices, and who are comfortable committing to a multi-month plan.

Read the review →

Ranked guides

Best hair loss telehealth providers Finasteride and minoxidil are the two treatments with real evidence, and every provider here prescribes them. The differences are price, formulation, and whether topical finasteride is offered for men who want to limit systemic exposure. 3 ranked

All providers

ClinicScoreConsultLabsPrescriberInsuranceFrom
Ro logoRo Also offers
A large direct-to-consumer telehealth company whose Ro Body programme prescribes branded GLP-1 medication, alongside its ED and hair-loss lines.
 9.0 Async Included MD/DO + NP/PA Yes $39 first month membership
Keeps
A hair-loss telehealth provider prescribing finasteride and minoxidil through an asynchronous consult.
 8.3* Async n/a MD/DO + NP/PA Cash $20/mo for first 3 months
Maximus logoMaximus Also offers
A men’s health telehealth brand offering TRT and enclomiphene protocols, a GLP-1 weight-loss programme, and hair and sexual health products.
 6.8* Hybrid Extra MD/DO — $99.99/mo
Hims & Hers Also offers
A publicly traded direct-to-consumer telehealth company offering weight-loss, sexual health, hair-loss and mental health treatment through an asynchronous model.
 6.7* Async Extra MD/DO + NP/PA Cash $39 first month membership

Head-to-head comparisons

Hims & Hers vs KeepsHims & Hers vs RoHenry Meds vs RoFound vs RoCalibrate vs RoHone Health vs MaximusFountain TRT vs MaximusBlokes vs Maximus

Tools for this decision

Annual care costWhich care path fits you?

What these clinics prescribe

Reference records for the compounds offered in this category. Mechanism, dosing ranges, evidence level and regulatory status for each.

  • Semaglutide — A long-acting GLP-1 receptor agonist and the compound that reset expectations for pharmacological weight loss.
  • Tirzepatide — A dual GIP and GLP-1 receptor agonist that produced greater weight loss than semaglutide in head-to-head trial data.

References

Regulatory and primary sources

  1. FDA: Drugs@FDA (finasteride, minoxidil) ↗ · approved hair-loss treatments and labeling
  2. HHS: Telehealth for patients ↗ · what to expect from a telehealth visit
  3. FDA: BeSafeRx, buying medicine online safely ↗ · how to check an online pharmacy
  4. NABP: Safe.Pharmacy verified websites ↗ · pharmacy accreditation lookup
  5. FSMB DocInfo: physician license lookup ↗ · check a prescriber is licensed
  6. FTC: Endorsements, influencers and reviews ↗ · disclosure rules for affiliate links

Published literature

  1. Piraccini BM, Blume-Peytavi U, Scarci F, et al.. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial.J Eur Acad Dermatol Venereol 2022.PubMed 34634163 · doi:10.1111/jdv.17738
  2. Penha MA, Miot HA, Kasprzak M, et al.. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.JAMA Dermatol 2024.PubMed 38598226 · doi:10.1001/jamadermatol.2024.0284
  3. Lee S, Lee YB, Choe SJ, et al.. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.Acta Derm Venereol 2019.PubMed 30206635 · doi:10.2340/00015555-3035
  4. Olsen EA, Dunlap FE, Funicella T, et al.. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.J Am Acad Dermatol 2002.PubMed 12196747 · doi:10.1067/mjd.2002.124088
  5. Kaufman KD, Olsen EA, Whiting D, et al.. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.J Am Acad Dermatol 1998.PubMed 9777765 · doi:10.1016/s0190-9622(98)70007-6
  6. Sobral MVS, Moreira JLML, Rodrigues LK, et al.. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials.Int J Dermatol 2025.PubMed 39425514 · doi:10.1111/ijd.17524
  7. Ahmed KMA, Kozaa YA, Abuawwad MT, et al.. Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis.Arch Dermatol Res 2025.PubMed 40056230 · doi:10.1007/s00403-025-04032-1
  8. Rossi A, Caro G. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.J Cosmet Dermatol 2024.PubMed 37798906 · doi:10.1111/jocd.15953

Literature retrieved from PubMed on October 18, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.